Peter Olagunju - 09 Dec 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role
Chief Technical Officer
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Dec 2022
Net transactions value
-$5,298
Form type
4
Filing time
13 Dec 2022, 19:24:08 UTC
Previous filing
09 Dec 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRR Common Stock Sale $1,765 -1,561 -5.4% $1.13 27,361 09 Dec 2022 Direct F1
transaction TCRR Common Stock Sale $1,766 -1,610 -5.9% $1.10 25,751 12 Dec 2022 Direct F1
transaction TCRR Common Stock Sale $1,767 -1,659 -6.4% $1.06 24,092 13 Dec 2022 Direct F1
holding TCRR Common Stock 28,922 09 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.